May 19, 2023
- May 18, 2024

Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of Hypertrophic Cardiomyopathy

EARNed Credits


AMA PRA Category 1 CreditTM



This CME program, derived from content presented at the European Association of Cardiovascular Imaging Annual Congress EACVI 2023 in Barcelona, Spain, will highlight how to optimize echocardiographic and CMR assessment in the diagnosis and management of hypertrophic cardiomyopathy. In hypertrophic cardiomyopathy, multimodality imaging is crucial to confirm diagnosis, assess for presence and mechanism of left ventricular outflow tract obstruction, and risk stratification for sudden cardiac death. Comfort with echocardiographic techniques to optimize visualization and with cardiac MRI as indicated and as available is required to make best utilization of new therapies for HCM. Our expert faculty will review both research-oriented and practice-pertinent information on the best use of imaging in the contemporary diagnosis and management of HCM.

Who Should Attend

Healthcare providers across the cardiac care spectrum who perform, interpret, and/or operationalize into the clinical context the results of cardiac imaging studies in patients with or at risk for HCM. This includes cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons, and other HCPs worldwide, as exemplified by those HCPs attending the EACVI2023 Annual Congress.

Provided By

Course Faculty

Thor Edvardsen, MD, PhD
Oslo University Hospital
Head, Department of Cardiology
EACVI, Past President 2018-2020
Oslo, Norway
Denisa Muraru, MD, PhD
EACVI Vice-President – Echocardiography Heart Valve Clinic Coordinator, San Luca Hospital, Auxologico IRCCS Associate Professor Department of Medicine and Surgery, University of Milano-Bicocca Milan, Italy
Elif Sade, MD
Chair Education Committee, European Association of Cardiovascular- EACVI Imaging Professor of Medicine University of Pittsburgh – Heart & Vascular Institute UPMC Pittsburgh, PA Baskent University Cardiology Department Ankara, Turkey

Learning Objectives


Deeper familiarity and comfort with the clinical interpretation of appropriately performed cardiac imaging studies (echocardiography and CMR) in patients with or at risk for HCM


An improved understanding of the prevalence, pathophysiology, unmet patient needs, and natural course of HCM


Operational confidence in recognizing the indications to treat, longitudinally manage, and/or refer to subspecialists, patients diagnosed with HCM


Awareness and understanding of the clinical trial data evaluating the efficacy and safety of new and emerging treatment options for HCM

Additional Course Information

It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:
Thor Edvardsen, MD, PhD Nothing to disclose
Denisa Muraru, MD, PhD SpeakerGE HealthCare; Philips Medical Systems
L. Elif Sade, MD Nothing to disclose

Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Chelsey Simonds and Nicole McMenamin hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM.

Clinicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been supported by an independent educational grant from Bristol Myers Squibb.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Learners who receive a grade of 60% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
  • CME and CNE credit will be issued appropriate certificate of completion.
  • Others may request a “certificate of completion”.
  1. Learners should claim only the credit commensurate with the extent of their participation in the activity.

For all CE inquiries or special needs, please contact [email protected].

May 19, 2023
- May 18, 2024

Optimizing Echocardiographic and CMR Assessment in the Diagnosis and Management of Hypertrophic Cardiomyopathy

Related Webcast Courses

Hypertrophic Cardiomyopathy: New Evidence, Updated Guidelines to Support Optimal Managemen...
VTE and Anticoagulation – Guideline Updates for 2024
Shared Decision-Making and Patient Education to Promote Adherence to DOACs and Continuity ...